Mesoblast Operational Highlights and Upcoming Milestones

Results from Phase 3 trial of rexlemestrocel-L (MPC-06-ID) in 404 patients with chronic low back pain (CLBP) due to degenerative disc disease (DDD) …
Source: back pain